Super‐Stable Homogeneously Sustained‐Release System Mediates Transcatheter Arterial Ionic‐Embolization Strategy for Hepatocellular Carcinoma Therapy
Advanced Functional Materials · 2024-03 · 34 (11)
DOI: 10.1002/adfm.202311505 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, 2023-12. Verfasst von Xuqi Peng und 17 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Major State Basic Research Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
The clinical effectiveness of locoregional therapies in treating hepatocellular carcinoma (HCC) is frequently constrained by multi‐drug resistance and/or tumor metastasis. To surmount these challenges, a promising approach, transcatheter arterial ionic‐embolization (TAIE) is proposed, which can specifically and continuously disrupt the intracellular ionic balance to significantly inhibit tumor activity and invasion. The hydrophilic micro‐nanoscale sodium chloride particles (SCPs) are ingeniously intermixed with hydrophobic lipiodol to create a super‐stable homogeneous embolic formulation (lipiodol‐sodium chloride, LSC). After interventional administration, the LSC selectively deposits in HCC lesions, where lipiodol stably delivers SCPs to disrupt the cell's ionic balance, causing cell death without drug resistance. Notably, it is demonstrated that LSC can significantly hinder tumor cell migration and invasion. The mechanism is through SCP disruption of the ionic balance, which induces cell swelling and subsequent vimentin hydrolysis‐mediated cytoskeletal remodeling. In addition, it is found that LSC treatment notably downregulates the expression of MYLK, TLN, and THBS2 genes in the focal adhesion (FA) signaling pathway of HepG2 cells. LSC formulation integrated tumor‐specific deposition, intratumoral sustained release, efficient tumoricidal activity, significant metastasis inhibition, and excellent biological safety, thereby demonstrating superior in vivo tumor therapeutic effects via TAIE strategy, and showing a promising cancer therapeutic approach for clinical application.
Förderung
- Major State Basic Research Development Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- China Postdoctoral Science Foundation
- Shenzhen Science and Technology Innovation Program
- Program for New Century Excellent Talents in University
- Natural Science Foundation of Fujian Province
Zitieren
APA
Peng, X., Zheng, Y., Xue, Y., Liang, X., He, P., Chen, H., He, P., Peng, Y., Zhao, Z., Chen, Y., Gui, X., Yang, L., Xiong, Y., Lin, J., Shi, Y., Chu, C., Zhang, Y., & Liu, G. (2024). Super‐Stable Homogeneously Sustained‐Release System Mediates Transcatheter Arterial Ionic‐Embolization Strategy for Hepatocellular Carcinoma Therapy. Advanced Functional Materials, 34(11). https://doi.org/10.1002/adfm.202311505
Vancouver
Peng X, Zheng Y, Xue Y, Liang X, He P, Chen H, et al. Super‐Stable Homogeneously Sustained‐Release System Mediates Transcatheter Arterial Ionic‐Embolization Strategy for Hepatocellular Carcinoma Therapy. Advanced Functional Materials. 2024;34(11). doi:10.1002/adfm.202311505
BibTeX
@article{Peng2024,
author = {Peng, Xuqi and Zheng, Yating and Xue, Yi and Liang, Xiaoliu and He, Pan and Chen, Hu and He, Peng and Peng, Yisheng and Zhao, Zhenwen and Chen, Yulun and Gui, Xiran and Yang, Lei and Xiong, Yongfu and Lin, Juan and Shi, Yesi and Chu, Chengchao and Zhang, Yang and Liu, Gang},
title = {Super‐Stable Homogeneously Sustained‐Release System Mediates Transcatheter Arterial Ionic‐Embolization Strategy for Hepatocellular Carcinoma Therapy},
journal = {Advanced Functional Materials},
year = {2024},
volume = {34},
number = {11},
doi = {10.1002/adfm.202311505}
}
EUVIMED